Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey (published 2014) The Center for Health Policy in collaboration with the Indiana Professional Licensing Agency and the State Prescription Drug Abuse Prevention Task Force’s Education Committee developed a web-based survey to gather information on prescribers’ and dispensers’ knowledge, use, and opinions of INSPECT as well as to assess prescribers’ and dispensers’ attitudes and beliefs about prescribing and dispensing opioids. Key findings suggest that both providers and dispensers are strongly supportive and frequent users of the INSPECT program; the majority of users believe INSPECT is generally effective and a valuable tool in state-wide efforts to reduce the misuse, abuse, and diversion of prescription drugs.
The Indiana INSPECT Evaluation: Key Findings and Recommendations from a Descriptive Analysis of INSPECT Data (published 2014) The purpose of this report is to provide a descriptive analysis of 2011-2013 INSPECT data. Most of the controlled substances dispensed in the observed time period were opioids, especially hydrocodone bitartrate and acetaminophen combinations (e.g., Vicodin®) . Benzodiazepines also contributed to a large portion of dispensations. Potential doctor-shoppers were more likely to be younger and had filled a higher number of opioid prescriptions than individuals characterized as non-shoppers. More dispensations of opioid analgesics were attributable to MDs than any other profession with prescription privileges.